g. Precursors as follows: 1. BCMO (3,3-bis(chloromethyl)oxetane) (CAS 78-71-7); 2. Dinitroazetidine-t-butyl salt (CAS 125735-38-8); 3. Hexaazaisowurtzitane derivates including HBIW (hexabenzylhexaazaisowurtzitane) (CAS 124782-15-6) (see also ML8.a.4.) and TAIW (tetraacetyldibenzylhexaazaisowurtzitane) (CAS 182763-60-6) (see also ML8.a.4.); 4. This entry is not used; 5. TAT (1,3,5,7-tetraacetyl-1,3,5,7-tetraaza cyclo-octane) (CAS 41378-98-7); 6. 1,4,5,8-tetraazadecalin (CAS 5409-42-7); 7. 1,3,5-trichlorobenzene (CAS 108-70-3); 8. 1,2,4-trihydroxybutane (1,2,4-butanetriol) (CAS 3068-00-6); 9. DADN (1,5-diacetyl-3,7-dinitro-1,3,5,7-tetraaza-cyclooctane) (see also ML8.a.13.) ;